Your payment is in progress...
  +1 (704) 266-3234

Global Monoclonal Antibody Therapy Market Size, Status And Forecast 2019-2025

Published on: Jul 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 99

Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages.
Therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signaling pathways. One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell-specific antigens and induce an immune response against the target cancer cell.In addition, monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-_.
In 2018, the global Monoclonal Antibody Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Monoclonal Antibody Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Monoclonal Antibody Therapy development in United States, Europe and China.

The key players covered in this study
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
...

Market segment by Type, the product can be split into
Recombinant
Chimeric
Humanized
Human

Market segment by Application, split into
Diagnostic Test
Analytical And Chemical Uses
Cancer Treatment
Autoimmune Diseases
Hematological Disorders

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Monoclonal Antibody Therapy status, future forecast, growth opportunity, key market and key players.
To present the Monoclonal Antibody Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Monoclonal Antibody Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Recombinant
1.4.3 Chimeric
1.4.4 Humanized
1.4.5 Human
1.5 Market by Application
1.5.1 Global Monoclonal Antibody Therapy Market Share by Application (2014-2025)
1.5.2 Diagnostic Test
1.5.3 Analytical And Chemical Uses
1.5.4 Cancer Treatment
1.5.5 Autoimmune Diseases
1.5.6 Hematological Disorders
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Monoclonal Antibody Therapy Market Size
2.2 Monoclonal Antibody Therapy Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapy Market Size by Regions (2014-2025)
2.2.2 Monoclonal Antibody Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Monoclonal Antibody Therapy Market Size by Manufacturers
3.1.1 Global Monoclonal Antibody Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Monoclonal Antibody Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Monoclonal Antibody Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Monoclonal Antibody Therapy Key Players Head office and Area Served
3.3 Key Players Monoclonal Antibody Therapy Product/Solution/Service
3.4 Date of Enter into Monoclonal Antibody Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Monoclonal Antibody Therapy Market Size by Type (2014-2019)
4.2 Global Monoclonal Antibody Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Monoclonal Antibody Therapy Market Size (2014-2019)
5.2 Monoclonal Antibody Therapy Key Players in United States
5.3 United States Monoclonal Antibody Therapy Market Size by Type
5.4 United States Monoclonal Antibody Therapy Market Size by Application

6 Europe
6.1 Europe Monoclonal Antibody Therapy Market Size (2014-2019)
6.2 Monoclonal Antibody Therapy Key Players in Europe
6.3 Europe Monoclonal Antibody Therapy Market Size by Type
6.4 Europe Monoclonal Antibody Therapy Market Size by Application

7 China
7.1 China Monoclonal Antibody Therapy Market Size (2014-2019)
7.2 Monoclonal Antibody Therapy Key Players in China
7.3 China Monoclonal Antibody Therapy Market Size by Type
7.4 China Monoclonal Antibody Therapy Market Size by Application

8 Japan
8.1 Japan Monoclonal Antibody Therapy Market Size (2014-2019)
8.2 Monoclonal Antibody Therapy Key Players in Japan
8.3 Japan Monoclonal Antibody Therapy Market Size by Type
8.4 Japan Monoclonal Antibody Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Monoclonal Antibody Therapy Market Size (2014-2019)
9.2 Monoclonal Antibody Therapy Key Players in Southeast Asia
9.3 Southeast Asia Monoclonal Antibody Therapy Market Size by Type
9.4 Southeast Asia Monoclonal Antibody Therapy Market Size by Application

10 India
10.1 India Monoclonal Antibody Therapy Market Size (2014-2019)
10.2 Monoclonal Antibody Therapy Key Players in India
10.3 India Monoclonal Antibody Therapy Market Size by Type
10.4 India Monoclonal Antibody Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Monoclonal Antibody Therapy Market Size (2014-2019)
11.2 Monoclonal Antibody Therapy Key Players in Central & South America
11.3 Central & South America Monoclonal Antibody Therapy Market Size by Type
11.4 Central & South America Monoclonal Antibody Therapy Market Size by Application

12 International Players Profiles
12.1 Abbvie
12.1.1 Abbvie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Monoclonal Antibody Therapy Introduction
12.1.4 Abbvie Revenue in Monoclonal Antibody Therapy Business (2014-2019)
12.1.5 Abbvie Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Monoclonal Antibody Therapy Introduction
12.2.4 Amgen Revenue in Monoclonal Antibody Therapy Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Glaxosmithkline
12.3.1 Glaxosmithkline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Monoclonal Antibody Therapy Introduction
12.3.4 Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2014-2019)
12.3.5 Glaxosmithkline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Monoclonal Antibody Therapy Introduction
12.4.4 Merck Revenue in Monoclonal Antibody Therapy Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Monoclonal Antibody Therapy Introduction
12.5.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2014-2019)
12.5.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Monoclonal Antibody Therapy Key Market Segments
Table Key Players Monoclonal Antibody Therapy Covered
Table Global Monoclonal Antibody Therapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Monoclonal Antibody Therapy Market Size Market Share by Type 2014-2025
Figure Recombinant Figures
Table Key Players of Recombinant
Figure Chimeric Figures
Table Key Players of Chimeric
Figure Humanized Figures
Table Key Players of Humanized
Figure Human Figures
Table Key Players of Human
Table Global Monoclonal Antibody Therapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Diagnostic Test Case Studies
Figure Analytical And Chemical Uses Case Studies
Figure Cancer Treatment Case Studies
Figure Autoimmune Diseases Case Studies
Figure Hematological Disorders Case Studies
Figure Monoclonal Antibody Therapy Report Years Considered
Table Global Monoclonal Antibody Therapy Market Size 2014-2025 (Million US$)
Figure Global Monoclonal Antibody Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Monoclonal Antibody Therapy Market Size by Regions 2014-2025 (Million US$)
Table Global Monoclonal Antibody Therapy Market Size by Regions 2014-2019 (Million US$)
Table Global Monoclonal Antibody Therapy Market Share by Regions 2014-2019
Figure Global Monoclonal Antibody Therapy Market Share by Regions 2014-2019
Figure Global Monoclonal Antibody Therapy Market Share by Regions 2019
Table Market Top Trends
Table Global Monoclonal Antibody Therapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Monoclonal Antibody Therapy Market Share by Manufacturers (2014-2019)
Figure Global Monoclonal Antibody Therapy Market Share by Manufacturers in 2018
Table Global Monoclonal Antibody Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Monoclonal Antibody Therapy Product/Solution/Service
Table Date of Enter into Monoclonal Antibody Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Monoclonal Antibody Therapy Market Size Share by Type (2014-2019)
Figure Global Monoclonal Antibody Therapy Market Size Market Share by Type (2014-2019)
Table Global Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Monoclonal Antibody Therapy Market Size Share by Application (2014-2019)
Figure Global Monoclonal Antibody Therapy Market Size Market Share by Application (2014-2019)
Figure Global Monoclonal Antibody Therapy Revenue Market Share by Application in 2018
Figure United States Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table United States Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table United States Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table United States Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table United States Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table United States Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table United States Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Figure Europe Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table Europe Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table Europe Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table Europe Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table Europe Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Figure China Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table China Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table China Monoclonal Antibody Therapy Market Size by Type (2014-20189) (Million US$)
Table China Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table China Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table China Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Figure Japan Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table Japan Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table Japan Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table Japan Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table Japan Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Figure Southeast Asia Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table Southeast Asia Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table Southeast Asia Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Figure India Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table India Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table India Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table India Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table India Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table India Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Figure Central & South America Monoclonal Antibody Therapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Monoclonal Antibody Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Monoclonal Antibody Therapy Market Share (2018-2019)
Table Central & South America Monoclonal Antibody Therapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Monoclonal Antibody Therapy Market Share by Type (2014-2019)
Table Central & South America Monoclonal Antibody Therapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Monoclonal Antibody Therapy Market Share by Application (2014-2019)
Table Abbvie Company Details
Table Abbvie Revenue in Monoclonal Antibody Therapy Business (2014-2019) (Million US$)
Figure Abbvie Revenue Growth Rate in Monoclonal Antibody Therapy Business (2014-2019)
Table Abbvie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Monoclonal Antibody Therapy Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Monoclonal Antibody Therapy Business (2014-2019)
Table Amgen Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2014-2019)(Million US$)
Figure Glaxosmithkline Revenue Growth Rate in Monoclonal Antibody Therapy Business (2014-2019)
Table Glaxosmithkline Recent Development
Table Merck Company Details
Table Merck Revenue in Monoclonal Antibody Therapy Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Monoclonal Antibody Therapy Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Monoclonal Antibody Therapy Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Monoclonal Antibody Therapy Business (2014-2019)
Table Novartis Recent Development
Table Global Monoclonal Antibody Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Monoclonal Antibody Therapy Market Size Share by Regions (2019-2025)
Figure Global Monoclonal Antibody Therapy Market Size Share by Regions in 2025
Figure United States Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Figure China Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Figure India Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Monoclonal Antibody Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Monoclonal Antibody Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Monoclonal Antibody Therapy Market Size by Product (2019-2025)
Figure Global Monoclonal Antibody Therapy Market Size by Product in 2025
Table Global Monoclonal Antibody Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Monoclonal Antibody Therapy Market Size by Application (2019-2025)
Figure Global Monoclonal Antibody Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.